Ro Launches GLP-1 Supply Tracker Amid Rising Drug Costs

The new tool aims to help patients locate weight loss and diabetes medications during shortages, addressing affordability concerns.

Ro's tracker provides real-time data on GLP-1 drug availability by location and dosage.
The tool is free and open to all, regardless of enrollment in Ro's programs.
GLP-1 drugs like Wegovy and Ozempic face high demand but limited supply, creating a national health issue.
Senator Bernie Sanders has raised concerns about the high costs of these medications potentially bankrupting the healthcare system.
Efforts to make these drugs more affordable are ongoing, with discussions about government intervention and price negotiations.